glp-1 therapy mandeville Weekly Rundown: gene enters first human trial GLP-1² Advanced Weight Loss Therapy

Last weeks JAMA had two articles on GLP-1 drugs that point to their promise for treatment of diseases beyond the conditions for which they are already approved by the FDA: obesity, diabetes, cardiovascular risk, sleep apnea and metabolic liver disease

J Clin Invest (2016) 126(5):16309

Iron accumulation in ovarian microenvironment damages the local redox balance and oocyte quality in aging mice

The study involved data from 16,827 patients evaluated by neuro-ophthalmologists, and focused on patients with type 2 diabetes or those who were overweight or obese, comparing those prescribed semaglutide to those using non-glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications

These devices use fuel cell technology to measure your breath alcohol concentration (BrAC), the presence of alcohol molecules in your breath sample no gum, mint or food will prevent the device from detecting the presence of alcohol